Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patent · clear
In the high-stakes world of intellectual property, patents are more than legal protections—they’re sometimes million-dollar chess pieces in a global game of innovation dominance. As companies race to secure patents over breakthroughs in…
The U.S. Patent and Trademark Office (USPTO) is set for a leadership change as President Donald Trump has nominated John Squires to serve as the next Director. Squires, a veteran intellectual property attorney with experience in both corporate and private…
On February 28, 2025, the United States Patent and Trademark Office (USPTO) rescinded the June 21, 2022, memorandum titled “Interim Procedure for Discretionary Denials in AIA Post-Grant Proceedings with Parallel District Court Litigation.”…
The U.S. International Trade Commission saw a rise in Section 337 investigations in 2024, with filings increasing 40% year over year to 70 cases—a reversal from 2023’s 36.71% decline. This rebound underscores the ITC’s key role in global…
In the fast-changing world of intellectual property, staying ahead requires more than legal expertise—it demands data-driven insights into the trends that are shaping patent prosecution. Over the past five years, significant shifts have been…
The International Trade Commission’s (ITC) Section 337 investigations have long been a critical tool for addressing unfair trade practices and safeguarding intellectual property rights in the United States. As these cases grow more prominent in the…
In the high-stakes, fast-paced world of patent litigation, staying ahead isn’t just about legal expertise—it’s about owning the data. Tomorrow, Patexia releases its highly anticipated 2025 Patent Litigation Report, a game-changing…
Next week, we are releasing the Patent Litigation Intelligence Report 2025, a comprehensive analysis of the U.S. patent litigation landscape. This report offers an all-encompassing view of key trends, from filing-related statistics and outcome analysis to…
Shares of Intra-Cellular Therapies (NASDAQ: ITCI) increased by nearly 15% last week after the company reached a significant settlement with Sandoz in the ongoing Caplyta (lumateperone) patent litigation. The announcement , which coincides with major…
The year 2024 has seen an uptick in patent litigation, reversing the downward trend observed since 2022. This increase underscores the growing importance of intellectual property in today's highly competitive and innovation-driven marketplace. As…
Huawei Technologies has recently taken legal action against MediaTek, alleging patent infringement. The lawsuit, filed in a Chinese court, is part of Huawei's broader strategy to enhance revenue through licensing fees and royalties. MediaTek, a…
The landscape of patent litigation has seen significant shifts over the past five years, and the first half of 2024 makes no exception presenting notable trends and developments. In particular, Q2 has marked an increase of 16% in patent litigation compared…
